#United States #New York #The Gross Law Firm #Sana Biotechnology #SANA

Class Action Notice: Shareholders for Sana Biotechnology, Inc.

The Gross Law Firm is reaching out to all shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA) who acquired shares within the class period from March 17, 2023, to November 4, 2024. If you purchased shares during this timeframe, now is the time to act – the deadline for joining the class action lawsuit is May 20, 2025.

Background of the Case

The allegations against Sana Biotechnology center around misinformation provided to investors regarding the company’s financial health and operational capacity. During the class period, it is claimed that the defendants falsely portrayed Sana's ability to maintain its operations and misrepresented the potential of its product candidates, SC291 in oncology, SC379, and SG299. Specifically, the complaint outlines several critical issues:

• - Financial Misrepresentation: There are claims that the defendants overstated the firm’s financial stability, misleading shareholders into believing the company could sustain its operational costs and continue advancing its product pipeline.
• - Product Misleading: The products SC291, SC379, and SG299 were touted as more promising than they actually were, which raises concerns about the validity of the information provided to shareholders.
• - Operational Reductions: To alleviate financial pressure, it is suggested that Sana intended to reduce funding for certain projects and significantly cut its workforce, risking its ability to sustain operations.

Given the alleged sidelining of significant risk factors, investors saw their investments adversely affected, leading to a potential basis for a class action to reclaim losses.

Call to Action for Shareholders

Shareholders are encouraged to register their details as soon as possible to confirm their participation in the class action. The Gross Law Firm will provide updates and monitor the case, ensuring that those who register are kept informed about the status of the proceedings through specialized software for ongoing case updates.

Importantly, even shareholders who do not want to be lead plaintiffs can still join the case and receive potential recovery without incurring costs or obligations.

Contact Information

The Gross Law Firm has a robust reputation in the arena of class action lawsuits and is dedicated to protecting the rights of investors affected by deceptive practices. Should you have further inquiries or wish to register, contact them directly:

• - Email: [email protected]
• - Phone: (646) 453-8903
• - Address: The Gross Law Firm, 15 West 38th Street, 12th floor, New York, NY, 10018

If you have been impacted by the developments regarding Sana Biotechnology, now is the time to take action before the deadline arrives. Ensure your rights as a shareholder are protected and consider joining the class action to pursue justice and potential recovery for your losses.

Why Choose The Gross Law Firm?

With years of experience and dedication to investor rights, The Gross Law Firm stands out for its commitment to holding companies accountable for illegal business practices. Their efforts focus on ensuring fair treatment of all shareholders impacted by corporate misrepresentation. Every stakeholder deserves a fair chance to seek recovery for losses incurred due to unethical practices, and The Gross Law Firm remains steadfast in that pursuit.

Stay vigilant and protect your investments: join the class action lawsuit today!